Show simple item record

FieldValueLanguage
dc.contributor.authorRischin, A.en_AU
dc.contributor.authorLiew, D.en_AU
dc.contributor.authorBlack, R.en_AU
dc.contributor.authorFletcher, A.en_AU
dc.contributor.authorBuchbinder, R.en_AU
dc.contributor.authorLassere, M.en_AU
dc.contributor.authorMarch, L.en_AU
dc.contributor.authorRobinson, P.C.en_AU
dc.contributor.authorHill, C.en_AU
dc.contributor.authorBarrett, C.en_AU
dc.contributor.authorCarroll, G.en_AU
dc.contributor.authorMarine, F.en_AU
dc.contributor.authorSchachna, L.en_AU
dc.contributor.authorSinnathurai, P.en_AU
dc.contributor.authorThe ARAD Steering Committeeen_AU
dc.date.accessioned2021-06-25T05:24:54Z
dc.date.available2021-06-25T05:24:54Z
dc.date.issued2021
dc.identifier.urihttps://hdl.handle.net/2123/25498
dc.description.abstractommunity restrictions due to COVID-19 have changed healthcare, including increased telehealth use. During the early pandemic phase, a cohort of Australian patients with inflammatory arthritis was surveyed. Self-reported access to healthcare was maintained and physical health was more likely to be self-rated poorly than mental health. There was a high level of support for telehealth during and after the pandemic.en_AU
dc.language.isoenen_AU
dc.subjectCOVID-19en_AU
dc.subjectCoronavirusen_AU
dc.titleHealthcare access and attitudes towards telehealth during the early phase of the COVID-19 pandemic among an Australian cohort with inflammatory arthritisen_AU
dc.typeArticleen_AU
dc.identifier.doi10.1111/imj.15309
dc.relation.otherAstraZenecaen_AU
dc.relation.otherRocheen_AU
dc.relation.otherNHMRC 384330en_AU
dc.relation.otherPfizer Australiaen_AU
dc.relation.otherMonash Universityen_AU


Show simple item record

Associated file/s

There are no files associated with this item.

Associated collections

Show simple item record

There are no previous versions of the item available.